ISU Abxis (Korea) Investor Sentiment

086890 Stock  KRW 5,840  190.00  3.15%   
About 62% of ISU Abxis' investor base is looking to short. The analysis of current outlook of investing in ISU Abxis Co suggests that many traders are alarmed regarding ISU Abxis' prospects. The current market sentiment, together with ISU Abxis' historical and current headlines, can help investors time the market. In addition, many technical investors use ISU Abxis stock news signals to limit their universe of possible portfolio assets.
  
over a week ago at news.google.com         
ISU Abxis Co., Ltd. Held Back By Insufficient Growth Even After Shares Climb 26 percent - Simply Wal...
Google News at Macroaxis
over a month ago at news.google.com         
Even after rising 12 percent this past week, ISU Abxis shareholders are still down 29 percent over t...
Google News at Macroaxis
over a month ago at news.google.com         
Fabry Disease Treatment Market Top Companies Study - Sanofi SA, - openPR
Google News at Macroaxis
over a month ago at news.google.com         
ISU ABXIS, a subsidiary of ISU Group, announced on the 10th that Professor Kim Seok-hos team at Don....
Google News at Macroaxis
over two months ago at news.google.com         
Celltrion to roll out record cash and stock dividends - The Korea JoongAng Daily
Google News at Macroaxis
over two months ago at news.google.com         
ISU Abxis Gaucher disease drug enters Middle East-North African market - KBR
Google News at Macroaxis
over three months ago at news.google.com         
Why Investors Shouldnt Be Surprised By ISU Abxis Co., Ltd.s 26 percent Share Price Plunge - Simply W...
Google News at Macroaxis
over three months ago at news.google.com         
ISU Abxis Takes On Some Risk With Its Use Of Debt - Simply Wall St
Google News at Macroaxis
over three months ago at news.google.com         
Fabry Disease Treatment Market Size, Share, Growth and Forecast to 2031 - InsightAce Analytic
Google News at Macroaxis
over six months ago at news.google.com         
ISU Abxis Co., Ltd.s Intrinsic Value Is Potentially 84 percent Above Its Share Price - Simply Wall S...
Google News at Macroaxis
over six months ago at news.google.com         
Sotio, Biocytogen link up in 325M ADC discovery pact - BioWorld Online
Google News at Macroaxis
over six months ago at news.google.com         
Cancer Cachexia Market Report 2034 FDA, EMA, PDMA Approvals, Clinical Trials, Pipeline, Epidemiology...
Google News at Macroaxis
over six months ago at news.google.com         
ISU Abxis Takes On Some Risk With Its Use Of Debt - Simply Wall St
Google News at Macroaxis
over six months ago at news.google.com         
Atypical Hemolytic Uremic Syndrome - Drugs In Development ... - GlobalData
Google News at Macroaxis
over six months ago at news.google.com         
Amicus Therapeutics First Quarter 2024 Earnings EPS Misses Expectations - Simply Wall St
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about ISU Abxis that are available to investors today. That information is available publicly through ISU media outlets and privately through word of mouth or via ISU internal channels. However, regardless of the origin, that massive amount of ISU data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of ISU Abxis news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of ISU Abxis relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to ISU Abxis' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive ISU Abxis alpha.

ISU Abxis Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Complementary Tools for ISU Stock analysis

When running ISU Abxis' price analysis, check to measure ISU Abxis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ISU Abxis is operating at the current time. Most of ISU Abxis' value examination focuses on studying past and present price action to predict the probability of ISU Abxis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ISU Abxis' price. Additionally, you may evaluate how the addition of ISU Abxis to your portfolios can decrease your overall portfolio volatility.
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm